RESUMEN
In this article we review the history of key epidemiological studies of populations exposed to ionizing radiation. We highlight historical and recent findings regarding radiation-associated risks for incidence and mortality of cancer and non-cancer outcomes with emphasis on study design and methods of exposure assessment and dose estimation along with brief consideration of sources of bias for a few of the more important studies. We examine the findings from the epidemiological studies of the Japanese atomic bomb survivors, persons exposed to radiation for diagnostic or therapeutic purposes, those exposed to environmental sources including Chornobyl and other reactor accidents, and occupationally exposed cohorts. We also summarize results of pooled studies. These summaries are necessarily brief, but we provide references to more detailed information. We discuss possible future directions of study, to include assessment of susceptible populations, and possible new populations, data sources, study designs and methods of analysis.
Asunto(s)
Neoplasias Inducidas por Radiación , Exposición a la Radiación , Radiación Ionizante , Humanos , Exposición a la Radiación/efectos adversos , Neoplasias Inducidas por Radiación/epidemiología , Neoplasias Inducidas por Radiación/etiología , Historia del Siglo XX , Estudios Epidemiológicos , Historia del Siglo XXI , Exposición ProfesionalRESUMEN
BACKGROUND: Chronic lymphocytic leukemia (CLL) was the predominant leukemia in a recent study of Chornobyl cleanup workers from Ukraine exposed to radiation (UR-CLL). Radiation risks of CLL significantly increased with increasing bone marrow radiation doses. Current analysis aimed to clarify whether the increased risks were due to radiation or to genetic mutations in the Ukrainian population. METHODS: A detailed characterization of the genomic landscape was performed in a unique sample of 16 UR-CLL patients and age- and sex-matched unexposed general population Ukrainian-CLL (UN-CLL) and Western-CLL (W-CLL) patients (n = 28 and 100, respectively). RESULTS: Mutations in telomere-maintenance pathway genes POT1 and ATM were more frequent in UR-CLL compared to UN-CLL and W-CLL (both p < 0.05). No significant enrichment in copy-number abnormalities at del13q14, del11q, del17p or trisomy12 was identified in UR-CLL compared to other groups. Type of work performed in the Chornobyl zone, age at exposure and at diagnosis, calendar time, and Rai stage were significant predictors of total genetic lesions (all p < 0.05). Tumor telomere length was significantly longer in UR-CLL than in UN-CLL (p = 0.009) and was associated with the POT1 mutation and survival. CONCLUSIONS: No significant enrichment in copy-number abnormalities at CLL-associated genes was identified in UR-CLL compared to other groups. The novel associations between radiation exposure, telomere maintenance and CLL prognosis identified in this unique case series provide suggestive, though limited data and merit further investigation.
Asunto(s)
Accidente Nuclear de Chernóbil , Genoma Humano/efectos de la radiación , Leucemia Linfocítica Crónica de Células B/epidemiología , Neoplasias Inducidas por Radiación/epidemiología , Exposición Profesional , Exposición a la Radiación , Adulto , Estudios de Casos y Controles , Femenino , Estudios de Seguimiento , Genómica , Humanos , Incidencia , Leucemia Linfocítica Crónica de Células B/etiología , Masculino , Persona de Mediana Edad , Neoplasias Inducidas por Radiación/etiología , Prevalencia , Dosis de Radiación , Ucrania/epidemiología , Adulto JovenRESUMEN
Breast cancer is the second leading cause of cancer death among women worldwide and besides life style, age and genetic risk factors, exposure to ionizing radiation is known to increase the risk for breast cancer. Further, DNA copy number alterations (CNAs), which can result from radiation-induced double-strand breaks, are frequently occurring in breast cancer cells. We set out to identify a signature of CNAs discriminating breast cancers from radiation-exposed and non-exposed female patients. We analyzed resected breast cancer tissues from 68 exposed female Chernobyl clean-up workers and evacuees and 68 matched non-exposed control patients for CNAs by array comparative genomic hybridization analysis (aCGH). Using a stepwise forward-backward selection approach a non-complex CNA signature, that is, less than ten features, was identified in the training data set, which could be subsequently validated in the validation data set (p value < 0.05). The signature consisted of nine copy number regions located on chromosomal bands 7q11.22-11.23, 7q21.3, 16q24.3, 17q21.31, 20p11.23-11.21, 1p21.1, 2q35, 2q35, 6p22.2. The signature was independent of any clinical characteristics of the patients. In all, we identified a CNA signature that has the potential to allow identification of radiation-associated breast cancer at the individual level.
Asunto(s)
Neoplasias de la Mama/genética , Accidente Nuclear de Chernóbil , Variaciones en el Número de Copia de ADN , Neoplasias Inducidas por Radiación/genética , Exposición a la Radiación/efectos adversos , Adulto , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/patología , Estudios de Cohortes , Hibridación Genómica Comparativa , Femenino , Estudios de Seguimiento , Dosificación de Gen , Genómica , Humanos , Persona de Mediana Edad , Invasividad Neoplásica , Neoplasias Inducidas por Radiación/epidemiología , Neoplasias Inducidas por Radiación/patología , Pronóstico , Curva ROC , Ucrania/epidemiologíaRESUMEN
The Chernobyl reactor accident in 1986 has caused significant exposure to ionizing radiation of the Ukrainian population, in particular clean-up workers and evacuees from the exclusion zones. A study aiming at the discovery of radiation markers of the breast cancer was conducted from 2008 to 2015 within a collaborative project by HZM, LMU, and NRCRM. In this study, post-Chernobyl breast cancer cases both in radiation-exposed female patients diagnosed at age less than 60 from 1992 to 2014 and in non-exposed controls matched for residency, tumor type, age at diagnosis, TNM classification as well as tumor grading were investigated for molecular changes with special emphasis to copy number alterations and miRNA profiles. Cancer registry and clinical archive data were used to identify 435 breast cancer patients among female clean-up workers and 14 among evacuees from highly contaminated territories as candidates for the study. Of these, 129 breast cancer patients fit study inclusion criteria and were traced for individual reconstruction of the target organ (breast) doses. The doses were estimated for 71 exposed cases (clean-up workers and evacuees from which biomaterial was available for molecular studies and who agreed to participate in a dosimetric interview) by the use of the well-established RADRUE method, which was adjusted specifically for the assessment of breast doses. The results of 58 female clean-up workers showed a large inter-individual variability of doses in a range of about five orders of magnitude: from 0.03 to 929 mGy, with median of 5.8 mGy. The study provides the first quantitative estimate of exposures received by female clean-up workers, which represent a limited but very important group of population affected by the Chernobyl accident. The doses of 13 women evacuated after the accident who did not take part in the clean-up activities (from 4 to 45 mGy with median of 19 mGy) are in line with the previous estimates for the evacuees from Pripyat and the 30-km zone.
Asunto(s)
Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/epidemiología , Accidente Nuclear de Chernóbil , Restauración y Remediación Ambiental , Neoplasias Inducidas por Radiación/diagnóstico , Neoplasias Inducidas por Radiación/epidemiología , Exposición Profesional/efectos adversos , Adulto , Neoplasias de la Mama/etiología , Relación Dosis-Respuesta a Droga , Relación Dosis-Respuesta en la Radiación , Femenino , Humanos , Neoplasias Inducidas por Radiación/etiología , Ucrania/epidemiologíaRESUMEN
Ionizing radiation is a well-recognized risk factor for the development of breast cancer. However, it is unknown whether radiation-specific molecular oncogenic mechanisms exist. We investigated post-Chernobyl breast cancers from radiation-exposed female clean-up workers and nonexposed controls for molecular changes. Radiation-associated alterations identified in the discovery cohort (n = 38) were subsequently validated in a second cohort (n = 39). Increased expression of hsa-miR-26b-5p was associated with radiation exposure in both of the cohorts. Moreover, downregulation of the TRPS1 protein, which is a transcriptional target of hsa-miR-26b-5p, was associated with radiation exposure. As TRPS1 overexpression is common in sporadic breast cancer, its observed downregulation in radiation-associated breast cancer warrants clarification of the specific functional role of TRPS1 in the radiation context. For this purpose, the impact of TRPS1 on the transcriptome was characterized in two radiation-transformed breast cell culture models after siRNA-knockdown. Deregulated genes upon TRPS1 knockdown were associated with DNA-repair, cell cycle, mitosis, cell migration, angiogenesis and EMT pathways. Furthermore, we identified the interaction partners of TRPS1 from the transcriptomic correlation networks derived from gene expression data on radiation-transformed breast cell culture models and sporadic breast cancer tissues provided by the TCGA database. The genes correlating with TRPS1 in the radiation-transformed breast cell lines were primarily linked to DNA damage response and chromosome segregation, while the transcriptional interaction partners in the sporadic breast cancers were mostly associated with apoptosis. Thus, upregulation of hsa-miR-26b-5p and downregulation of TRPS1 in radiation-associated breast cancer tissue samples suggests these molecules representing radiation markers in breast cancer.
Asunto(s)
Neoplasias de la Mama/metabolismo , Accidente Nuclear de Chernóbil , Proteínas de Unión al ADN/biosíntesis , MicroARNs/biosíntesis , Neoplasias Inducidas por Radiación/metabolismo , Factores de Transcripción/biosíntesis , Adulto , Neoplasias de la Mama/etiología , Neoplasias de la Mama/genética , Proteínas de Unión al ADN/genética , Femenino , Humanos , MicroARNs/genética , Persona de Mediana Edad , Neoplasias Inducidas por Radiación/etiología , Neoplasias Inducidas por Radiación/genética , Adhesión en Parafina , Proteínas Represoras , Factores de Transcripción/genéticaRESUMEN
The recently demonstrated radiation-induction of chronic lymphocytic leukemia (CLL) raises the question as to whether the amount of radiation exposure influences any of the clinical characteristics of the disease. We evaluated the relationship between bone marrow radiation doses and clinical characteristics and survival of 79 CLL cases diagnosed during 1986-2006 in a cohort of 110 645 male workers who participated in the cleanup work of the Chornobyl nuclear accident in Ukraine in 1986. All diagnoses were confirmed by an independent International Hematology Panel. Patients were followed up to the date of death or end of follow-up on 31 October 2010. The median age at diagnosis was 57 years. Median bone marrow dose was 22.6 milligray (mGy) and was not associated with time between exposure and clinical diagnosis of CLL (latent period), age, peripheral blood lymphocyte count or clinical stage of disease in univariate and multivariate analyses. Latent period was significantly shorter among those older at first exposure, smokers and those with higher frequency of visits to the doctor prior to diagnosis. A significant increase in the risk of death with increasing radiation dose was observed (p = 0.03, hazard ratio = 2.38, 95% confidence interval: 1.11,5.08 comparing those with doses ≥22 mGy to doses <22 mGy). After adjustment for radiation dose, survival of CLL cases was significantly shorter among those with younger age at first exposure, higher peripheral blood lymphocyte count, more advanced clinical stage of disease and older age at diagnosis (all p < 0.05). This is the first study to examine association between bone marrow radiation doses from the Chornobyl accident and clinical manifestations of the CLL in Chornobyl cleanup workers. The current study provides new evidence on the association of radiation dose and younger age at first radiation exposure at Chornobyl with shorter survival after diagnosis. Future studies are necessary with more cases in order to improve the statistical power of these analyses and to determine their significance. Copyright © 2016 John Wiley & Sons, Ltd.
Asunto(s)
Accidente Nuclear de Chernóbil , Leucemia Linfocítica Crónica de Células B/etiología , Leucemia Inducida por Radiación/etiología , Exposición Profesional/efectos adversos , Adulto , Anciano , Humanos , Leucemia Linfocítica Crónica de Células B/mortalidad , Leucemia Inducida por Radiación/mortalidad , Masculino , Persona de Mediana Edad , Dosis de RadiaciónRESUMEN
BACKGROUND: Risks of most types of leukemia from exposure to acute high doses of ionizing radiation are well known, but risks associated with protracted exposures, as well as associations between radiation and chronic lymphocytic leukemia (CLL), are not clear. OBJECTIVES: We estimated relative risks of CLL and non-CLL from protracted exposures to low-dose ionizing radiation. METHODS: A nested case-control study was conducted in a cohort of 110,645 Ukrainian cleanup workers of the 1986 Chornobyl nuclear power plant accident. Cases of incident leukemia diagnosed in 1986-2006 were confirmed by a panel of expert hematologists/hematopathologists. Controls were matched to cases on place of residence and year of birth. We estimated individual bone marrow radiation doses by the Realistic Analytical Dose Reconstruction with Uncertainty Estimation (RADRUE) method. We then used a conditional logistic regression model to estimate excess relative risk of leukemia per gray (ERR/Gy) of radiation dose. RESULTS: We found a significant linear dose response for all leukemia [137 cases, ERR/Gy = 1.26 (95% CI: 0.03, 3.58]. There were nonsignificant positive dose responses for both CLL and non-CLL (ERR/Gy = 0.76 and 1.87, respectively). In our primary analysis excluding 20 cases with direct in-person interviews < 2 years from start of chemotherapy with an anomalous finding of ERR/Gy = -0.47 (95% CI: < -0.47, 1.02), the ERR/Gy for the remaining 117 cases was 2.38 (95% CI: 0.49, 5.87). For CLL, the ERR/Gy was 2.58 (95% CI: 0.02, 8.43), and for non-CLL, ERR/Gy was 2.21 (95% CI: 0.05, 7.61). Altogether, 16% of leukemia cases (18% of CLL, 15% of non-CLL) were attributed to radiation exposure. CONCLUSIONS: Exposure to low doses and to low dose-rates of radiation from post-Chornobyl cleanup work was associated with a significant increase in risk of leukemia, which was statistically consistent with estimates for the Japanese atomic bomb survivors. Based on the primary analysis, we conclude that CLL and non-CLL are both radiosensitive.
Asunto(s)
Accidente Nuclear de Chernóbil , Leucemia Inducida por Radiación/epidemiología , Exposición Profesional/efectos adversos , Estudios de Casos y Controles , Humanos , Linfocitos/efectos de la radiación , Radiación IonizanteRESUMEN
BACKGROUND: Although high doses of ionizing radiation have long been linked to circulatory disease, evidence for an association at lower exposures remains controversial. However, recent analyses suggest excess relative risks at occupational exposure levels. OBJECTIVES: We performed a systematic review and meta-analysis to summarize information on circulatory disease risks associated with moderate- and low-level whole-body ionizing radiation exposures. METHODS: We conducted PubMed/ISI Thomson searches of peer-reviewed papers published since 1990 using the terms "radiation" AND "heart" AND "disease," OR "radiation" AND "stroke," OR "radiation" AND "circulatory" AND "disease." Radiation exposures had to be whole-body, with a cumulative mean dose of < 0.5 Sv, or at a low dose rate (< 10 mSv/day). We estimated population risks of circulatory disease from low-level radiation exposure using excess relative risk estimates from this meta-analysis and current mortality rates for nine major developed countries. RESULTS: Estimated excess population risks for all circulatory diseases combined ranged from 2.5%/Sv [95% confidence interval (CI): 0.8, 4.2] for France to 8.5%/Sv (95% CI: 4.0, 13.0) for Russia. CONCLUSIONS: Our review supports an association between circulatory disease mortality and low and moderate doses of ionizing radiation. Our analysis was limited by heterogeneity among studies (particularly for noncardiac end points), the possibility of uncontrolled confounding in some occupational groups by lifestyle factors, and higher dose groups (> 0.5 Sv) generally driving the observed trends. If confirmed, our findings suggest that overall radiation-related mortality is about twice that currently estimated based on estimates for cancer end points alone (which range from 4.2% to 5.6%/Sv for these populations).
Asunto(s)
Enfermedades Cardiovasculares/etiología , Enfermedades Cardiovasculares/mortalidad , Relación Dosis-Respuesta en la Radiación , Exposición a Riesgos Ambientales , Traumatismos por Radiación/etiología , Traumatismos por Radiación/mortalidad , Radiación Ionizante , Enfermedades Cardiovasculares/epidemiología , Humanos , Exposición Profesional , Traumatismos por Radiación/epidemiología , Monitoreo de RadiaciónRESUMEN
The Chernobyl accident, which occurred on 26 April 1986 at a nuclear power plant located less than 150 km north of Kiev, was the largest nuclear accident to date. The unprecedented scale of the accident was determined not only by the amount of released activity, but also by the number of workers and of the general public involved, and therefore exposed to increased doses of ionising radiation. Due to the unexpected and large scale of the accident, dosimetry techniques and practices were far from the optimum; personal dosimetry of cleanup workers (liquidators) was not complete, and there were no direct measurements of the exposures of members of the public. As a result, an acute need for retrospective dose assessment was dictated by radiation protection and research considerations. In response, substantial efforts have been made to reconstruct doses for the main exposed cohorts, using a broad variety of newly developed methods: analytical, biological and physical (electron paramagnetic resonance spectroscopy of teeth, thermoluminescence of quartz) and modelling. This paper reviews the extensive experience gained by the National Research Center for Radiation Medicine, Academy of Medical Sciences, Ukraine in the field of retrospective dosimetry of large cohorts of exposed population and professionals. These dose reconstruction projects were implemented, in particular, in the framework of epidemiological studies, designed to follow-up the medical consequences of the Chernobyl accident and study health effects of ionizing radiation, particularly Ukrainian-American studies of cataracts and leukaemia among liquidators.
Asunto(s)
Artefactos , Accidente Nuclear de Chernóbil , Neoplasias Inducidas por Radiación/epidemiología , Plantas de Energía Nuclear/estadística & datos numéricos , Dosis de Radiación , Radiometría/métodos , Humanos , Incidencia , Medición de Riesgo/métodos , Factores de Riesgo , Ucrania/epidemiologíaRESUMEN
After the accident that took place on 26 April 1986 at the Chornobyl nuclear power plant, hundreds of thousands of cleanup workers were involved in emergency measures and decontamination activities. In the framework of an epidemiological study of leukemia and other related blood diseases among Ukrainian cleanup workers, individual bone marrow doses have been estimated for 572 cases and controls. Because dose records were available for only about half of the study subjects, a time-and-motion method of dose reconstruction that would be applicable to all study subjects, whether dead or alive, was developed. The doses were calculated in a stochastic mode, thus providing estimates of uncertainties. The arithmetic mean individual bone marrow doses were found to range from 0.00004 to 3,300 mGy, with an average value of 87 mGy over the 572 study subjects. The uncertainties, characterized by the geometric standard deviation of the probability distribution of the individual dose, varied from subject to subject and had a median value of about 2. These results should be treated as preliminary; it is likely that the dose calculations and particularly the uncertainty estimates will be improved in the follow-up of this effort.
Asunto(s)
Médula Ósea/efectos de la radiación , Accidente Nuclear de Chernóbil , Restauración y Remediación Ambiental , Leucemia/epidemiología , Neoplasias Inducidas por Radiación/epidemiología , Exposición Profesional , Dosis de Radiación , Adulto , Anciano , Estudios de Casos y Controles , Estudios de Cohortes , Humanos , Masculino , Persona de Mediana Edad , Mieloma Múltiple/epidemiología , Síndromes Mielodisplásicos/epidemiología , Radiometría , Reproducibilidad de los Resultados , Encuestas y Cuestionarios , Factores de Tiempo , Ucrania/epidemiología , Estados UnidosRESUMEN
Leukemia is one of the cancers most susceptible to induction by ionizing radiation, but the effects of lower doses delivered over time have not been quantified adequately. After the Chornobyl (Chernobyl) accident in Ukraine in April 1986, several hundred thousand workers who were involved in cleaning up the site and its surroundings received fractionated exposure, primarily from external gamma radiation. To increase our understanding of the role of protracted low-dose radiation exposure in the etiology of leukemia, we conducted a nested case-control study of leukemia in a cohort of cleanup workers identified from the Chornobyl State Registry of Ukraine. The analysis is based on 71 cases of histologically confirmed leukemia diagnosed in 1986-2000 and 501 age- and residence-matched controls selected from the same cohort. Study subjects or their proxies were interviewed about their cleanup activities and other relevant factors. Individual bone marrow radiation doses were estimated by the RADRUE dose reconstruction method (mean dose = 76.4 mGy, SD = 213.4). We used conditional logistic regression to estimate leukemia risks. The excess relative risk (ERR) of total leukemia was 3.44 per Gy [95% confidence interval (CI) 0.47-9.78, P < 0.01]. The dose response was linear and did not differ significantly by calendar period of first work in the 30-km Chornobyl zone, duration or type of work. We found a similar dose-response relationship for chronic and non-chronic lymphocytic leukemia [ERR = 4.09 per Gy (95% CI < 0-14.41) and 2.73 per Gy (95% CI < 0-13.50), respectively]. To further clarify these issues, we are extending the case-control study to ascertain cases for another 6 years (2001-2006).
Asunto(s)
Accidente Nuclear de Chernóbil , Restauración y Remediación Ambiental , Leucemia/epidemiología , Leucemia/etiología , Neoplasias Inducidas por Radiación/epidemiología , Exposición Profesional , Adulto , Distribución por Edad , Anciano , Estudios de Casos y Controles , Estudios de Cohortes , Humanos , Leucemia/patología , Modelos Logísticos , Masculino , Proteínas de la Membrana , Persona de Mediana Edad , Dosis de Radiación , Medición de Riesgo , Factores de Tiempo , Proteínas Supresoras de Tumor , Ucrania/epidemiología , Estados UnidosRESUMEN
A case-control study of hematological malignancies was conducted among Chernobyl liquidators (accident recovery workers) from Belarus, Russia and Baltic countries to assess the effect of low- to medium-dose protracted radiation exposures on the relative risk of these diseases. The study was nested within cohorts of liquidators who had worked around the Chernobyl plant in 1986-1987. A total of 117 cases [69 leukemia, 34 non-Hodgkin lymphoma (NHL) and 14 other malignancies of lymphoid and hematopoietic tissue] and 481 matched controls were included in the study. Individual dose to the bone marrow and uncertainties were estimated for each subject. The main analyses were restricted to 70 cases (40 leukemia, 20 NHL and 10 other) and their 287 matched controls with reliable information on work in the Chernobyl area. Most subjects received very low doses (median 13 mGy). For all diagnoses combined, a significantly elevated OR was seen at doses of 200 mGy and above. The excess relative risk (ERR) per 100 mGy was 0.60 [90% confidence interval (CI) -0.02, 2.35]. The corresponding estimate for leukemia excluding chronic lymphoid leukemia (CLL) was 0.50 (90% CI -0.38, 5.7). It is slightly higher than but statistically compatible with those estimated from A-bomb survivors and recent low-dose-rate studies. Although sensitivity analyses showed generally similar results, we cannot rule out the possibility that biases and uncertainties could have led to over- or underestimation of the risk in this study.
Asunto(s)
Accidente Nuclear de Chernóbil , Restauración y Remediación Ambiental , Neoplasias Hematológicas/epidemiología , Neoplasias Inducidas por Radiación/epidemiología , Exposición Profesional , Adulto , Estudios de Casos y Controles , Neoplasias Hematológicas/etiología , Humanos , Persona de Mediana Edad , Dosis de Radiación , Medición de Riesgo , Sensibilidad y Especificidad , IncertidumbreRESUMEN
This paper presents a critical review of dosimetric monitoring practices during Chernobyl cleanup from 1986 to 1990. Dosimetric monitoring is considered in time evolution with respect to legislative background (including dose limits), methods of dose assessment, and coverage of workers with radiation monitoring programs as well as availability of data on individual doses of liquidators. Four large independent dosimetry services (Administration of Construction No. 605, Chernobyl Nuclear Power Plant, Production Association "Combinat," and the troops) had operated in Chernobyl covering different cohorts of cleanup workers with dosimetric monitoring of variable quality and comprehension. Extremes in this range were presented by the highly professional dosimetry service of the Administration of Construction No. 605 (USSR Ministry of Medium Machinery), which had provided total coverage of workers with high quality individual thermoluminescent dosimeter monitoring, and military (troops of the USSR Ministry of Defense) who had received the least precise group dosimetry, which, however, had covered the whole population of military cleanup workers. The main groups of liquidators are considered from the point of view of completeness and quality of their dosimetric data. Main gaps in dosimetric data and limitations of existing dose records are identified. The issues of evolution of dose limits and problems of monitoring internal and beta exposure are considered from the point of view of significance of these components and the need for missing information.
Asunto(s)
Accidente Nuclear de Chernóbil , Exposición Profesional/análisis , Dosis de Radiación , Rayos gamma , Humanos , Monitoreo de RadiaciónRESUMEN
During the first day after the explosion, the Chornobyl accident of April 26, 1986 exposed a few hundred emergency workers to high dose levels ranging up to 16 Gy, resulting in acute radiation syndrome. Subsequently, several hundred thousand cleanup workers were sent to the Chornobyl power plant to mitigate the consequences of the accident. Depending on the nature of the work to be carried out, the cleanup workers were sent for periods ranging from several minutes to several months. The average dose from external radiation exposure that was received by the cleanup workers was about 170 mGy in 1986 and decreased from year to year. The radiation exposure was mainly due to external irradiation from gamma-ray-emitting radionuclides and was relatively homogeneous over all organs and tissues of the body. To assess the possible health consequences of external irradiation at relatively low dose rates, the U.S. National Cancer Institute is involved in two studies of Chornobyl cleanup workers: (1) a study of cancer incidence and thyroid disease among Estonian, Latvian and Lithuanian workers, and (2) a study of leukemia and other related blood diseases among Ukrainian workers. After an overview of the sources of exposure and of the radiation doses received by the cleanup workers, a description of the efforts made to estimate individual doses in the Baltic and Ukrainian studies is presented.
Asunto(s)
Accidente Nuclear de Chernóbil , Descontaminación/estadística & datos numéricos , Exposición a Riesgos Ambientales/análisis , Neoplasias Inducidas por Radiación/epidemiología , Exposición Profesional/estadística & datos numéricos , Monitoreo de Radiación/métodos , Medición de Riesgo/métodos , Países Bálticos/epidemiología , Humanos , Centrales Eléctricas/estadística & datos numéricos , Dosis de Radiación , Liberación de Radiactividad Peligrosa/estadística & datos numéricos , Factores de Riesgo , Ucrania/epidemiologíaRESUMEN
A method for evaluating the overall uncertainty of alanine EPR transfer dosimetry in the therapeutic dose range is described. The method uses experimental data on EPR signal reproducibility from replicate dosimeters irradiated to low doses (1-5 Gy), estimates of Type B uncertainties, and Monte Carlo simulations of heteroscedastic orthogonal linear regression. A Bruker ECS106 spectrometer and Bruker alanine dosimeters have been used for this evaluation. The results demonstrate that alanine dosimetry can be used for transfer dosimetry in that range with the overall uncertainty 1.5-4% (1sigma) depending on the dose, the number of replicate dosimeters. and the duration of the calibration session (the session should not exceed one working day).